Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives

Blood Reviews(2022)10.1016/j.blre.2022.100996Source: DataRank Database

Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives is a research paper published in Blood Reviews (2022). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 5.33)OA: hybridTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Keri Maher ORCID,Steven Grant ORCID,Ian Bouligny ORCID

Live enrichment

PubMed:35989139 PMC:PMC10693933 OpenAlex:https://openalex.org/W4289444101

NIH

Grant: P30CA16059

NIH

Grant: R01CA205607

NIH

Grant: UM1CA186644

NCI NIH HHS

Grant: P30 CA016059

National Institutes of Health

Grant: 4P30CA016059-35

Massey Cancer Center Support Grant

National Institutes of Health

Grant: 5R01CA205607-04

Targeting Multiple Myeloma with Smac-mimetics and HDAC Inhibitors

National Institutes of Health

Grant: 3UM1CA186644-06S1

North American Star Consortium

Leukemia & Lymphoma Society

FWCI

5.33

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S0268960X22000704/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S0268960X22000704/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0268960X22000704?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0268960X22000704?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.blre.2022.100996

Fields of Study

Acute Myeloid Leukemia ResearchProtein Degradation and InhibitorsHistone Deacetylase Inhibitors Research0301 basic medicine0303 health sciences03 medical and health sciencesHumansLeukemia, Myeloid, AcuteBone MarrowTranscription FactorsEpigenesis, GeneticSignal TransductionTumor Microenvironment

MeSH Terms

Bone MarrowHumansTranscription FactorsSignal TransductionLeukemia, Myeloid, AcuteEpigenesis, GeneticTumor Microenvironment

Keywords

Myeloid leukemiaHaematopoiesisMyeloidEpigeneticsCancer researchBone marrowMedicineBiologyLeukemiaImmunologyBioinformaticsStem cellGeneticsGeneCell cycleSignal transductionTranscription factorAcute myeloid leukemiaOncoproteinTargeted TherapyLeukemogenesisNovel StrategiesLeukemia, Myeloid, AcuteTumor MicroenvironmentHumansArticleTranscription FactorsEpigenesis, Genetic

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being